P3 Health Partners Inc (NASDAQ:PIII) has a beta value of 0.94 and has seen 0.93 million shares traded in the recent trading session. The PIII stock price is -394.44% off its 52-week high price of $0.89 and 16.67% above the 52-week low of $0.15. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.48 million shares traded. The 3-month trading volume is 2.46 million shares.
The consensus among analysts is that P3 Health Partners Inc (PIII) is Buy stock at the moment, with a recommendation rating of 1.80. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
P3 Health Partners Inc (NASDAQ:PIII) trade information
Sporting -3.41% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PIII stock price touched $0.18 or saw a rise of 9.09%. Year-to-date, P3 Health Partners Inc shares have moved -21.19%, while the 5-day performance has seen it change -0.48%. Over the past 30 days, the shares of P3 Health Partners Inc (NASDAQ:PIII) have changed -3.19%. Short interest in the company has seen 2.34 million shares shorted with days to cover at 3.26.
P3 Health Partners Inc (PIII) estimates and forecasts
The company’s shares have lost -54.12% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -6.02%.
4 analysts offering their estimates for the company have set an average revenue estimate of 362.09M for the current quarter. 4 have an estimated revenue figure of 349.82M for the next ending quarter. Year-ago sales stood 388.49M and 379.16M respectively for this quarter and the next, and analysts expect sales will shrink by -6.79% for the current quarter and -6.02% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -8.00% over the past 5 years. Earnings growth for 2025 is a modest 51.06% while over the next 5 years, the company’s earnings are expected to increase by 41.31%.
PIII Dividends
P3 Health Partners Inc is expected to release its next earnings report on 2025-Mar-26 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
P3 Health Partners Inc (NASDAQ:PIII)’s Major holders
Insiders own 62.08% of the company shares, while shares held by institutions stand at 13.27% with a share float percentage of 35.00%. Investors are also buoyed by the number of investors in a company, with P3 Health Partners Inc having a total of 44.0 institutions that hold shares in the company. The top two institutional holders are ALYESKA INVESTMENT GROUP, L.P. with over 15.95 million shares worth more than $7.18 million. As of 2024-06-30, ALYESKA INVESTMENT GROUP, L.P. held 11.6756% of shares outstanding.
The other major institutional holder is ARMISTICE CAPITAL, LLC, with the holding of over 7.9 million shares as of 2024-06-30. The firm’s total holdings are worth over $3.56 million and represent 5.7833% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 0.89% shares in the company for having 1.45 shares of worth $0.26 million while later fund manager owns 462.69 shares of worth $83699.0 as of Jan 31, 2025, which makes it owner of about 0.28% of company’s outstanding stock.
